With 2023 shaping up to be defined by biotech-on-biotech mergers, Infinity Pharmaceuticals’ announcement in February that it was planning to merge with MEI Pharma didn’t raise too many eyebrows. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results